Paul D Rubin's Net Worth

$10.5 Million

Estimate Recalculated Sep 17, 2024 08:01PM EST

Who is Paul D Rubin?

Paul D Rubin has an estimated net worth of $10.5 Million. This is based on reported shares across multiple companies, which include XOMA LTD /DE/, MIRAGEN THERAPEUTICS, INC., and CRITICAL THERAPEUTICS INC.

SEC CIK

Paul D Rubin's CIK is 0001210905

Past Insider Trading and Trends

2013 was Paul D Rubin's most active year for acquiring shares with 16 total transactions. Paul D Rubin's most active month to acquire stocks was the month of January. 2005 was Paul D Rubin's most active year for disposing of shares, totalling 54 transactions. Paul D Rubin's most active month to dispose stocks was the month of September. 2014 saw Paul D Rubin paying a total of $981,103.76 for 269,849 shares, this is the most they've acquired in one year. In 2015 Paul D Rubin cashed out on 204,426 shares for a total of $518,406.91, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

XOMA Corp (XOMA) Snapshot price: $28.4

Sr. VP Clinical Dev. & CMO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.56%
-12.05K
$0.78
-$18,985.03
326.6K
Mar 18 - Mar 22
Form 4
+141.34%
198.33K
—
—
338.65K
Feb 25
Form 4
+13.03%
15.95K
$0.83
-$9,002.63
138.29K
Aug 14
Form 4
—
0
$3.82
-$7,792.00
122.34K
Scheduled
Jul 15
Form 4
—
0
$3.80
-$50,468.80
122.34K
Scheduled
Jul 9 - Jul 10
Form 4
+2.41%
2.88K
$3.60
-$6,436.80
122.34K
May 28
Form 4
-21.51%
-32.74K
$3.94
-$128,879.06
119.47K
Scheduled
Mar 23
Form 4
+6.89%
9.81K
$4.01
-$82,355.62
152.21K
Mar 18
Form 4
+83.74%
64.9K
—
—
142.4K
Feb 26
Form 4
—
0
$3.84
-$2,536.96
72.02K
Scheduled
Dec 15
Form 4
—
0
$3.80
-$7,550.00
72.02K
Scheduled
Nov 20
Form 4
—
0
$3.81
-$7,629.00
72.02K
Scheduled
Oct 28
Form 4
—
0
$3.82
-$7,738.50
72.02K
Scheduled
Sep 15
Form 4
—
0
$3.80
-$15,240.00
72.02K
Scheduled
Sep 4
Form 4
—
0
$4.34
-$116,093.50
72.02K
Scheduled
Aug 14 - Aug 18
Form 4
-13.85%
-11.58K
$4.54
-$52,595.20
72.02K
Scheduled
Jun 16
Form 4
+3.57%
2.88K
$4.22
-$7,532.70
83.6K
May 28
Form 4
-11.02%
-10.00K
$3.84
-$38,404.00
80.72K
May 13
Form 4
+25.96%
18.7K
$4.68
-$93,183.08
90.72K
Scheduled
Mar 18
Form 4
+2,131.13%
68.79K
—
—
72.02K
Feb 27
Form 4
—
0
$5.30
-$27,031.80
3.23K
Scheduled
Feb 18
Form 4
-8.66%
-306.00
$5.65
-$32,298.24
3.23K
Scheduled
Jan 21
Form 4
—
0
$4.36
-$15,751.80
3.53K
Scheduled
Dec 18
Form 4
—
0
$3.79
-$7,044.00
3.53K
Scheduled
Nov 27
Form 4
—
0
$3.22
-$2,239.75
3.53K
Scheduled
Nov 18
Form 4/A
-59.79%
-5.25K
$4.71
-$24,725.32
3.53K
Scheduled
Oct 18
Form 4
—
0
$3.54
-$1,750.12
8.79K
Scheduled
Oct 18
Form 4
+5.51%
459
$4.27
$1,957.86
8.79K
Sep 30
Form 4
-41.87%
-6.00K
$4.53
-$27,186.60
8.33K
Scheduled
Sep 18
Form 4
-29.51%
-6.00K
$3.74
-$22,419.00
14.33K
Scheduled
Aug 19
Form 4
+395.71%
16.23K
$3.86
-$40,620.88
20.33K
Aug 14
Form 4
—
0
$3.72
-$11,861.64
4.1K
Scheduled
Jul 18
Form 4
+16.04%
567
$3.45
$1,955.30
4.1K
Jun 28
Form 4
-44.82%
-2.87K
$2.36
$7,386.80
3.53K
Scheduled
Jun 18
Form 4
+81.21%
2.87K
$4.16
-$7,476.06
6.4K
May 28 - May 29
Form 4
-59.61%
-5.21K
$3.26
$1,852.60
3.53K
Scheduled
May 20
Form 4
-40.68%
-6.00K
—
—
8.75K
Scheduled
Apr 18
Form 4
+11.30%
1.5K
$3.32
$4,966.62
14.75K
Mar 28
Form 4
+550.83%
11.21K
$3.29
-$22,997.10
13.25K
Mar 18 - Mar 19
Form 4
—
0
—
—
0
Feb 28
Form 4
+69.24%
833
$2.28
$1,899.24
2.04K
Dec 31
Form 4
+82.00%
542
$3.51
$1,899.98
1.2K
Sep 28
Form 4
—
0
—
—
0
Jul 19
Form 4
-82.99%
-3.23K
$2.83
$1,871.29
661
Jun 15 - Jun 29
Form 4
—
0
—
—
0
May 24
Form 4
+46.24%
1.23K
$2.63
$3,234.11
3.89K
Mar 30
Form 4
—
0
—
—
0
Feb 10
Form 4
∞
1.02K
$1.66
$1,699.08
1.02K
Sep 30
Form 4
—
0
—
—
0
May 31
Form 3
—
0
—
—
0
No matching records found

MIRAGEN THERAPEUTICS, INC. (VRDN) Snapshot price: $14.09

EVP, Research & Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Feb 16
Form 3
—
0
—
—
0
No matching records found

CRITICAL THERAPEUTICS INC No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-38.95%
-72.93K
$0.38
-$27,714.54
114.3K
Mar 22
Form 4
-10.78%
-5.00K
$6.54
-$32,687.92
41.37K
Scheduled
Jan 30
Form 4
-9.73%
-5.00K
$6.70
-$33,497.00
46.37K
Scheduled
Jan 17
Form 4
-8.87%
-5.00K
$7.12
-$35,622.48
51.37K
Scheduled
Jan 3
Form 4
-8.15%
-5.00K
$3.55
$760.00
56.37K
Scheduled
Dec 15
Form 4
-7.53%
-5.00K
$6.43
-$32,136.06
61.37K
Scheduled
Nov 30
Form 4/A
-6.55%
-5.00K
$7.01
-$35,043.07
71.37K
Scheduled
Oct 31
Form 4/A
-6.14%
-5.00K
$8.65
-$43,267.20
76.37K
Scheduled
Oct 17
Form 4
-7.01%
-5.00K
$6.78
-$33,922.00
66.37K
Scheduled
Nov 15
Form 4
-6.55%
-5.00K
$7.01
-$35,043.00
71.37K
Scheduled
Oct 31
Form 4
-6.14%
-5.00K
$8.65
-$43,267.00
76.37K
Scheduled
Oct 17
Form 4/A
-12.47%
-13.00K
—
—
91.24K
Aug 22
Form 4
+5.97%
6.6K
—
—
91.24K
Aug 22
Form 4
—
0
—
—
143.9K
Dec 22
Form 4/A
—
0
—
—
0
Sep 8
Form 4
—
0
—
—
0
Sep 8
Form 4/A
+870.06%
58K
$0.40
$42,790.80
64.66K
Dec 19 - Mar 5
Form 3/A
—
0
—
—
0
Form 4
∞
92.57K
—
—
92.57K
Jun 2
Form 3
—
0
—
—
0
No matching records found